AKI patients were more common in HICs (62.1%) and had higher rates of lung or heart disease and use of beta-blockers, diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and anticoagulants. The gene discussed is ACE; the disease is heart disorder.